Our Story
AI-Enabled Analytics for the Next Generation of Real-World Evidence
Our Story
Panalgo is proud to be a part of the Norstella family of brands, one of the world’s largest global pharma intelligence solution providers. Norstella unites market-leading companies – Citeline, Evaluate, MMIT, Panalgo, Skipta and The Dedham Group – with a shared goal of smoothing the path to life-saving therapies for patients and providers.
Through partnerships across the industry, Panalgo streamlines access to real-world data (RWD) and delivers AI-powered analytics, helping life sciences organizations generate real-world evidence (RWE) faster. From access to data to industry-leading software to expert analytic services, Panalgo provides end-to-end evidence generation solutions for HEOR, epidemiology, regulatory, and commercial teams.
Where We Started...
Panalgo’s roots go back to 1996, when Boston Health Economics (BHE) was founded to deliver professional research and analytics services to the life sciences industry. Over time, the team recognized that traditional approaches to database analysis were holding the industry back — too slow, too complex, and too dependent on custom programming.
That insight sparked the development of Instant Health Data (IHD), Panalgo’s flagship platform, built to eliminate complex programming and make real-world data analysis faster and more accessible.
As healthcare data availability exploded, IHD grew with it — and so did our ambitions. In time, BHE became Panalgo: a name derived from “pan” (everything) and “algo” (algorithm) — an algorithm for everything. The rebrand reflected a sharper identity and a bigger mission: full-scale real-world evidence solutions for life sciences, payers, and providers.
Today, IHD is an industry-leading platform trusted by dozens of top life science and research organizations, helping clinical and commercial teams understand real-world payer and prescriber behavior — and connect the dots from pipeline to patient.